Table 5 Analysis of postoperative brain-sparing effect indicators in patients (`x±s)

The sufentanil group

59

29.32±1.31

24.38±2.47***

27.85±2.77^#

41.18±7.14

63.63±7.37***

54.25±5.11^##

The control group

59

29.36±1.48

21.28±3.03***

25.03±2.16^###

42.41±5.05

67.76±6.85***

68.76±6.18^###

F_{Treatment value}/P_{Treatment value}

4.196/0.041

5.513/0.013

F_{Time value}/P_{Time value}

4.738/0.038

4.973/0.034

F_{Treatment×Time value}/P_{Treatment×Time value}

3.976/0.046

9.254/0.001

Groups

n

S-jvO₂(%)

CEO₂(%)

Before surgery

24 hours after surgery

48 hours after surgery

Before surgery

24 hours after surgery

48 hours after surgery

The sufentanil group

59

72.83±5.25

61.24±4.17***

66.16±4.24^##

20.74±3.69

26.91±2.84***

21.28±3.18^#

The control group

59

73.53±5.38

65.65±4.23***

68.14±3.17^##

21.07±3.69

29.47±4.35***

25.25±3.03^###

F_{Treatment value}/P_{Treatment value}

4.689/0.030

9.778/0.001

F_{Time value}/P_{Time value}

6.836/0.027

10.326/0.001

F_{Treatment×Time value}/P_{Treatment×Time value}

10.201/0.001

12.785/0.001